Inventor

TERRETT JONATHAN ALEXANDER

US58 patents

⚠️ This page may combine multiple inventors who share the name “TERRETT JONATHAN ALEXANDER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TERRETT JONATHAN ALEXANDER

CRISPR THERAPEUTICS AG

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Methods and compositions for treating cancer

Materials and methods for engineering cells and uses thereof in immuno-oncology

Materials and methods for engineering cells and uses thereof in immuno-oncology

Methods and compositions for treating cancer

Genetically engineered T cells having improved persistence in culture

T-cells expressing anti-LIV1 chimeric antigen receptor

Anti-PTK7 immune cell cancer therapy

Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such

Methods and compositions for treating cancer

Allogeneic cell therapy of B cell malignancies using genetically engineered T cells targeting CD19

CYTOMX THERAPEUTICS INC

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof

Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof

Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

OXFORD BIOTHERAPEUTICS LTD

Methods of treating acute myeloid leukemia with antibodies to bone marrow stromal antigen 1

Antibodies to bone marrow stromal antigen 1

Conjugated antibodies against LY75 for the treatment of cancer

Nucleic acid encoding bone marrow stromal antigen 1 antibody

Antibodies

Antibodies to bone marrow stromal antigen 1

TERRETT JONATHAN ALEXANDER

Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

Human monoclonal antibodies to protein tyrosine kinase 7 (PTK7) and methods for using anti-PTK7 antibodies

Monoclonal antibodies against glypican-3

Treating lung cancer using human monoclonal antibodies to protein tyrosine kinase 7 (PTK7)

ROHLFF CHRISTIAN

Anti-ROR1 antibodies and methods of use for treatment of cancer

Antibody drug conjugate treatment of colorectal cancer

CELLTECH R&D LTD

Methods for diagnosis and treatment of epithelial-derived cancers

UCB PHARMA SA

Methods for diagnosis and treatment of epithelial-derived cancers

SMITHKLINE BEECHAM PLC

Tubby 2 polypeptides